Use more image captions as often as possible impacts and even the loss of a supply chain partner or a region .
“ This requires alternate supply arrangements , tight inventory level management to provide a needed buffer , and very agile operations .”
Dourlens goes on to stress that whatever the market conditions or challenges “ we are the one making available patients ’ drugs – on time and at the expected quality ”. He says that together with Marken , this “ is our duty , this is our DNA ”.
Dourlens and his team face the daily challenge of balancing risk and efficiency .
He says that in the wider world of supply chain businesses focus their efforts on cost and efficiency “ because supply chains can become very expensive and complicated ”. If a company puts too much emphasis on cost and efficiency , he says this can result in a lack of responsiveness .
“ Pandemic , earthquakes , regulatory changes or cyberattacks can easily disrupt our supply and impact business ,” he says . “ Recent acceleration of such disruptions has led to the breakdown of supply chains , because the resilience was not there .”
But in a pharma context the need to guarantee supplies is all important : “ In clinical trials , we are probably more aware
fintechmagazine . com 111